title: Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex.
abstract: The genetic basis for Glanzmann's thrombasthenia (GT) was elucidated on a compound heterozygote with glycoprotein (GP)IIb gene: an opal mutation at the end of exon 17 (CGA----TGA) results in only a trace amount of GPIIb mRNA, and a splicing mutation at the acceptor site of exon 26 (CAG----GAG) causes an in-frame, exon skipping process from exon 25 to 27. This aberrant transcript encodes a single-chain polypeptide characterized by a 42-amino acid deletion, which includes the proteolytic cleavage site(s) and a unique, proline-rich region at the location corresponding to the carboxyl-terminal of the normal GPIIb alpha-chain. These characteristics are shared by a previously reported defective GPIIb molecule, which is neither assembled with GPIIIa nor transported to the cellular surface. Despite its normal transcription level, expression of the present defective GPIIb molecule was significantly decreased (approximately 6% of the control level). Because the precursor GPIIb molecule is assembled with GPIIIa in the endoplasmic reticulum (ER) and its processing, as well as stability, is dependent on the GPIIIa subunit, the defective GPIIb molecule may be rapidly degraded by the intrinsic quality control system of the ER due to its inability to form a stable heterodimer complex as a consequence of its misfolded structure. Although we did not confirm that the GPIIIa genes of this individual were normal, GPIIIa may be secondarily decreased (approximately 11% of control), because a large part of it could not be complexed, making it vulnerable to proteolysis. To elucidate the molecular basis for GT, we propose here a classification of GT based on the biosynthetic pathway of the GPIIb-IIIa complex.
authors.affiliation: First Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Kato
authors.forename: K
authors.initials: K
authors.lastname: Yamamoto
authors.forename: S
authors.initials: S
authors.lastname: Miyazaki
authors.forename: S M
authors.initials: SM
authors.lastname: Jung
authors.forename: M
authors.initials: M
authors.lastname: Moroi
authors.forename: N
authors.initials: N
authors.lastname: Aoki
mesh_terms: D001483:Base Sequence; D001792:Blood Platelets / Q000378:metabolism; D002648:Child; D004247:DNA / Q000235:genetics; D004262:DNA Restriction Enzymes; D004721:Endoplasmic Reticulum / Q000378:metabolism; D005091:Exons; D015723:Gene Library; D006579:Heterozygote; D006801:Humans; D008297:Male; D009154:Mutation; D010980:Platelet Membrane Glycoproteins / Q000096:biosynthesis / Q000235:genetics*; D016133:Polymerase Chain Reaction; D012326:RNA Splicing; D012333:RNA, Messenger / Q000097:blood / Q000235:genetics; D012260:Ribonucleases / Q000378:metabolism; D013915:Thrombasthenia / Q000235:genetics*; D014158:Transcription, Genetic
chemical_list: D010980:Platelet Membrane Glycoproteins; D012333:RNA, Messenger; D004247:DNA; D012260:Ribonucleases; D004262:DNA Restriction Enzymes